Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2764)
All Articles published online
|
Oct 28, 2008 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Felga GEG, Silva FM, Barbuti RC, Navarro-Rodriguez T, Zaterka S, Eisig JN. Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease. World J Gastroenterol 2008; 14(40): 6224-6227 [PMID: 18985815 DOI: 10.3748/wjg.14.6224] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6224.htm |
| Number | Citing Articles |
| 1 |
Morris O. Makobongo, Hanan Gancz, Beth M. Carpenter, Dennis P. McDaniel, D. Scott Merrell.
The Oligo-Acyl Lysyl Antimicrobial Peptide C
12
K-2β
12
Exhibits a Dual Mechanism of Action and Demonstrates Strong
In Vivo
Efficacy against Helicobacter pylori
. Antimicrobial Agents and Chemotherapy 2012; 56(1): 378 doi: 10.1128/AAC.00689-11
|
| 2 |
Yuemiao Zhang, Wen Gao, Hong Cheng, Xuezhi Zhang, Fulian Hu. Tetracycline‐ and Furazolidone‐containing Quadruple Regimen as Rescue Treatment for Helicobacter pylori Infection: A Single Center Retrospective Study. Helicobacter 2014; 19(5): 382 doi: 10.1111/hel.12143
|
| 3 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Mohammad Reza Naghipour, Atena Forouhari, Seyed Mohammad Seyed Saadat. Seven-day quintuple regimen as a rescue therapy for <italic>Helicobacter pylori</italic> eradication. World Journal of Gastroenterology 2015; 21(2): 661-666 doi: 10.3748/wjg.v21.i2.661
|
| 4 |
Morris O. Makobongo, Tchelet Kovachi, Hanan Gancz, Amram Mor, D. Scott Merrell. In Vitro Antibacterial Activity of Acyl-Lysyl Oligomers againstHelicobacter pylori. Antimicrobial Agents and Chemotherapy 2009; 53(10): 4231 doi: 10.1128/AAC.00510-09
|
| 5 |
Vincenzo De Francesco, Enzo Ierardi, Cesare Hassan, Angelo Zullo. Is Furazolidone Therapy for Helicobacter pylori Effective and Safe?. Digestive Diseases and Sciences 2009; 54(10): 2298 doi: 10.1007/s10620-009-0748-x
|
| 6 |
Hafez Fakheri, Zohreh Bari, Hossein Sardarian. A modified Bismuth‐Containing Quadruple Therapy Including a Short Course of Furazolidone for Helicobacter pylori Eradication After Sequential Therapy Failure. Helicobacter 2012; 17(4): 264 doi: 10.1111/j.1523-5378.2012.00946.x
|
| 7 |
Hafez Fakheri, Tarang Taghvaei, Vahid Hosseini, Zohreh Bari. A Comparison between Sequential Therapy and a Modified Bismuth‐based Quadruple Therapy for Helicobacter pylori Eradication in Iran: A Randomized Clinical Trial. Helicobacter 2012; 17(1): 43 doi: 10.1111/j.1523-5378.2011.00896.x
|
| 8 |
Saghi Riahizadeh, Reza Malekzadeh, Shahram Agah, Nasrin Zendehdel, Rasoul Sotoudehmanesh, Naser Ebrahimi‐Dariani, Akram Pourshams, Homayoon Vahedi, Javad Mikaeli, Morteza Khatibian, Sadegh Massarrat. Sequential Metronidazole‐Furazolidone or Clarithromycin‐Furazolidone Compared to Clarithromycin‐Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double‐Blind Randomized Controlled Trial. Helicobacter 2010; 15(6): 497 doi: 10.1111/j.1523-5378.2010.00798.x
|
| 9 |
Ying-Chao Sun, Meng-Jia Zhu, Xue-Qin Chen, Lei Yue, Yi-Ru Zhao, Xin-Jie Wang, John J Kim, Qin Du, Wei-Ling Hu. Efficacy and safety of modified tetracycline dosing in a quadruple therapy for <i>Helicobacter pylori</i>: A retrospective single center study. World Journal of Gastroenterology 2023; 29(22): 3508-3518 doi: 10.3748/wjg.v29.i22.3508
|
| 10 |
Hong Cheng, Fu-Lian Hu. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori. World Journal of Gastroenterology 2009; 15(7): 860-864 doi: 10.3748/wjg.15.860
|
| 11 |
Vincenzo De Francesco, Enzo Ierardi, Cesare Hassan, Angelo Zullo. Furazolidone therapy for <italic>Helicobacter pylori</italic>: Is it effective and safe?. World Journal of Gastroenterology 2009; 15(15): 1914-1915 doi: 10.3748/wjg.15.1914
|
| 12 |
Bioactive heteroleptic Bismuth(V) carboxylates: Synthetic Stratagem, characterization and binding pattern validation. Journal of Organometallic Chemistry 2020; 921: 121357 doi: 10.1016/j.jorganchem.2020.121357
|
| 13 |
Reena Sangwan, Savita Beniwal, Seema Gaur, Phulwanti Sharma, Megha Mittal, Priyanka Sharma, Jyoti Sharma. Syntheses and characterization of novel antimony (III) and bismuth (III) derivatives containing β‐enamino ester along with antimicrobial evaluation, DFT calculation, and cytotoxic study. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23548
|
| 14 |
Airu Liu, Yuxin Wang, Yingxiao Song, Yiqi Du. Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection. Saudi Journal of Gastroenterology 2020; 26(2): 78 doi: 10.4103/sjg.SJG_589_19
|
| 15 |
Yong Xie, Yin Zhu, Hong Zhou, Zhi-Fa Lu, Zhen Yang, Xu Shu, Xiao-Bai Guo, Hui-Zhen Fan, Jian-Hua Tang, Xue-Ping Zeng, Jian-Bo Wen, Xiao-Qing Li, Xing-Xing He, Jiu-Hong Ma, Dong-Sheng Liu, Cai-Bin Huang, Ning-Jian Xu, Nong-Rong Wang, Nong-Hua Lu. Furazolidone-based triple and quadruple eradication therapy for <italic>Helicobacter pylori</italic> infection. World Journal of Gastroenterology 2014; 20(32): 11415-11421 doi: 10.3748/wjg.v20.i32.11415
|